Julie VanOrsdel Daves

Insider Reports History

Entity
Individual
Location
301 Carlson Parkway, Suite 210, Minneapolis, Minnesota
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julie VanOrsdel Daves:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. SVP Clinical Development Oper. Stock Option (right to buy) 54K Jun 1, 2023 Direct
DiaMedica Therapeutics Inc. SVP Clinical Development Oper. Voting Common Shares, no par value per share 0 $2.80 Jun 1, 2023 Direct

Insider Reports Filed by Julie VanOrsdel Daves

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 SVP Clinical Development Oper.
DMAC DiaMedica Therapeutics Inc. Sep 13, 2022 1 $0 4 Sep 15, 2022 SVP Clinical Development Oper.
DMAC DiaMedica Therapeutics Inc. Sep 13, 2022 0 $0 3 Sep 15, 2022 SVP Clinical Development Oper.